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ABSTRACT 
BACKGROUND: 
Previously the etiological factors of peptic ulcer is caused by stress, 
spicy foods before 1983 ,after that Warren and Marshall identified the 
relationship between the H. pylori infection and peptic ulcer.Now  it  
recognized that H. pylori is one of the  most common cause of peptic ulcer 
disease and the prevalence of   H. pylori varies with age, socioeconomic status 
and other associated risk factors, so diagnosing and controlling the H.pylori 
infection will reduce the mortality and morbidity of the Patient. 
AIM AND OBJECTIVES: 
 To study the association of H.pylori  in patients with perforated peptic 
ulcer by RUT and HPE  and to study the association between other risk factors 
and H.pylori infection.  
MATERIALS AND METHODS :  
About 50 cases  of   perforated  peptic (gastroduodenal) ulcer evaluated 
and analysed in  an  emergency  basis  in  general  surgery  department in  
coimbatore medical college and hospital for a period of between  July 2017  to  
July  2018  are  included  in  this  study. Emergency exploratory laparotomy  
has been  performed  in  all these cases due to peptic ulcer perforation. During 
 
 
 
 
intraoperatively , two  mucosal   biopsies  taken  from the  perforation  site and 
sent for RUT and HPE to detect H.Pylori infection. 
RESULT:   
Out of 50 cases of peptic ulcer perforation, 39 cases (78%) turned out to 
be positive for H.pylori. Out of 50, H.pylori status positive for  most of the 
middle aged persons (21-30 years) – 25.6 % and males were commonly 
affected  87.2 %. Acid peptic disease is most commonly asscociated with 
H.pylori positive patients around  84.6%. Post operatively H.pylori positive 
patients were put on anti H.pylori treatment. 
CONCLUSION 
 There was a high prevalence of H.pylori infection in patients with 
perforated peptic ulcer. Patient with perforated peptic ulcer gave history of 
chronic dyspepsia, should be treated with anti H.pylori therapy post operatively 
to reduce the recurrence and reperforation. 
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INTRODUCTION 
 
Peptic ulcer perforation is relatively common in our institute. Patients 
will present to the emergency department with features of  Perforative 
peritonitis such as abdominal pain ,guarding, rigidity and some patients present 
late with features of shock and hypovolemia and needed aggressive 
management for survival of the patient.So peptic ulcer perforation is relatively 
causing economical burden on health care services, so that diagnosing the 
condition earlier will give good prognosis. 
Previously the etiological factors of Peptic ulcer is caused by stress, 
spicy foods before 1983 ,after that Warren and Marshall identified the 
relationship between the H. pylori infection and peptic ulcer. Now  it  
recognized that H. pylori is one the  most common cause of peptic ulcer disease 
and the prevalence of   H. pylori varies with age, socioeconomic status and 
other associated risk factors, so diagnosing and controlling the H.pylori 
infection will reduce the mortality and morbidity of the Patient. 
         The realization that H. Pylori may have a fundamental role in the etiology 
& the pathogenesis of peptic ulcer disease and its complications. So therapeutic 
strategies aimed at eradicating this bacterium and curing the disease. 
Perforated peptic ulcer is most common in disease ranging 
approximately 7 to 10 cases per 100000 populations per year. Perforation is 
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one of the  complication of peptic ulcer disease is present in about 7% of 
patients were admitted in hospital. 
So that there is a necessity to study  the association of perforation in 
peptic ulcer disease, but the correlation between the perforated peptic ulcer and 
H.pylori is not yet fully established if proved the control of H.pylori  may 
reduce the economic burden on health services. 
        We are going to study the presence of H.pylori in all cases of perforated 
peptic ulcer by taking the peroperative mucosal biopsy and confirming it with 
RUT and HPE examination. 
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AIMS & OBJECTIVES 
The aim of this study is know the presence of H.pylori in patients with 
perforated peptic ulcer by using rapid urease test and histopathological 
examination 
Objectives of this studies are, 
1. To study the various etiological factors in peptic ulcer perforation. 
2. To study the cases of peptic ulcer perforation in relation to H. pylori 
infection  
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MATERIALS AND METHODS 
About 50 cases  of   perforated  peptic (gastroduodenal) ulcer evaluated 
and analysed in  an  emergency  basis  in  General  surgery  department in  
Coimbatore medical college and hospital for a period of between  July 2017  to  
July  2018  are  included  in  this  study. The details of 50 patients were 
arranged in the master chart. 
INCLUSION CRITERIA: 
1. Patients  of age group between  13-80 years.   
2. Patients undergoing emergency laparotomy with  features of 
perforative peritonitis due to peptic ulcer perforation.   
EXCLUSION CRITERIA: 
1. Patients  below  the age group of 13  years  and  above the age 
group of 80 years  
2. Pregnant patients ,                                                                                        
3. Patients presenting with perforative peritonitis due to trauma 
4. Patients received  Anti-H.pylori  treatment.  
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DURATION OF STUDY : 
 12 months ( July 2017 to July 2018) 
STUDY DESIGN : 
 PROSPECTIVE COHORT STUDY 
SAMPLE SIZE: 
50 
The   study   population   contains  of   50 patients  included between the  
age  group  of  13-80  yrs. Emergency  exploratory  laparotomy  has been  
performed  in  all these cases due to peptic ulcer perforation. 
   During intraoperatively , two  mucosal   biopsies  taken  from the  
perforation  site, in that  one  tissue sample is used  to perform rapid urease 
test(RUT)   immediately  and another tissue sample sent for histopathological 
examination  to detect   H.pylori  by giemsa staining. 
RAPID UREASE TEST:  
 We have taken  biopsy from the edge of ulcer in order to perform 
Rapid urease test 
 Urea solution is prepared by adding 10gm of urea powder in 10ml of 
distilled water which gives 1% urea solution 
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 1ml of this prepared urea solution is added to 2 sterile plain bulbs 
 One of which is labelled as control and other is labelled as test 
 2-3 drops of Phenol red is added (indicator) 
 Of 2-3mm thickness tissue sample taken from the edge of ulcer and 
added to this testing bulb 
PRINCIPLE: 
H.pylori secretes an enzyme-urease which catalyses conversion of urea 
to ammonia and bicarbonate there by raising the PH of medium which is 
interpreted by Colour change yellow to pink. 
INTERPRETATION: 
 If the colour changes from Yellow to Pink it is considered as 
Positive for H.pylori 
 If the colour doesn’t change from yellow to pink colour even after 24 
hours it is considered as negative for H.pylori  
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RAPID UREASE TEST 
 
 
FIGURE 1 
 
 
FIGURE 2 
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STAINING TECHNIQUE: 
The  Second tissue sample  is  fixed  in a  10%  formalin  solution  
further subjected  to  Giemsa  staining  in PATHOLOGY department 
demonstrating the histopathologic  characteristics  of  the  biopsy tissue  while  
optimally  demonstrating  H. pylori.  
FIXATION: 10% buffered neutral formalin solution 
SECTION: 3 microns 
PROCEDURE: 
 Deparaffinize and hydrate to distilled water  
 Place in methanol for 2 minutes 
 Pre heat working giemsa solution in microwave on high for 45 
seconds 
 Filter the hot solution into a coplin jar containing the slides 
 Stain for 2 minutes 
(To prepare the working solution mix with 7ml of giemsa stock ,38ml of 
distilled water and 5ml of methanol) 
 Rinse quickly in distilled water 
 Dip one slide at a time in acetic acid1% 
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 Rinse quickly in distilled water 
 Rinse in 3 changes of methanol 
 Clear in xylene and mount 
STAINING RESULTS: 
 H.Pylori -Dark blue 
 Tissue Elements – shades of blue and pink 
 
GIEMSA STAINING – H.pylori      
 
FIGURE 3 
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REVIEW OF LITERATURE 
 
ANATOMY OF STOMACH 
 Stomach is the most dilated part of the alimentary tract intervening 
between oesophagus and duodenum 
 It occupies the epigastric,hypochondrial and umbilical region of the 
abdomen 
 It is J-shaped when its empty and becomes pyriform shaped when 
partly distended 
 Mean capacity is 30ml (birth),1000ml(puberty),1.5-2lit(adult 
Stomach has two orifices (cardiac and pyloric), two curvatures(lesser and 
greater),two surfaces(anterior and posterior)                
PARTS OF STOMACH: 
 CARDIAC PART: Fundus & Body 
 PYLORIC PART : Pyloric Antrum & Pyloric Canal 
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GROSS ANATOMY OF STOMACH 
 
FIGURE 4 
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2 ORIFICES: 
• Proximal Cardiac Orifice  –  located 2 to 3cm left of the midline in the 
left 7th coastal cartilage 
• Distal Pyloric Orifice  –  located in transpyloric line 1.2 cm right of 
midline  
2 CURVATURES: 
• Lesser Curvature  – the most dependent part is marked by angular 
notch (incisura angularis) 
• Greater Curvature  –  a line drawn downward and left from this notch 
and divides the stomach into 2 parts.  
2 ANGLES 
• Incisura  Angularis 
• Angle Of His :  angle of entry of esophagus into the stomach which is 
30 to 70 degree. 
• Fundus is the part above the horizontal line drawn from the angle of his 
POSTERIOR SURFACE RELATIONS:(STRUCTES FORMING 
STOMACH BED) 
• Diaphragm  
• Left Kidney  
• Suprarenal Gland  
• Pancreas Body 
• Transverse Colon & Splenic Flexure Of Colon 
• Splenic  Artery  
 
 
13 
 
BLOOD SUPPLY TO STOMACH: 
ARTERIAL SUPPLY: 
The coeliac artery provides blood supply to the stomach 
There are 4 main arteries 
• Along lesser curvature 
o Left gastric artery from coeliac artery 
o Right gastric artery from common hepatic artery. 
• Along greater curvature 
o Right gastro omental artery from the gastroduodenal artery. 
o Left gastro omental artery and short gastric arteries from the 
splenic artery . 
• Fundus supplied by 5-7 short gastric arteries.   
VENOUS DRAINAGE OF STOMACH 
Veins of the stomach drain into portal, superior mesenteric and splenic vein 
• Left gastric vein and right gastric vein drain to portal vein. 
• Short gastric and left gastro epiploic vein drain into splenic vein. 
• Right gastric epiploic vein drain into superior mesenteric vein.  
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BLOOD SUPPLY OF STOMACH 
 
 
FIGURE 5 
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NERVE SUPPLY OF STOMACH 
• Intrinsic innervation occur through myenteric auerbach plexus, 
submucosal plexus of meissener 
• Extrinsic innervation occur by 
• Parasympathetic – vagus nerve (left anterior vagus and right 
posterior vagus. Criminal nerve of grassi is the first branch of 
Right vagus nerve- it is recognized as the potential cause of 
recurrent ulcer. Both anterior and posterior vagus gives off 
splanchnic branches, pyloric branches and nerve of later jet. 
• Sympathetic – coeliac ganglia (T6-T9 spinal nerve segment) 
 
FIGURE 6 
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LYMPHATIC DRAINAGE : 
Lymphatic drainage of stomach is divided into 4 zones 
Superior Gastric group (left gastric, paracardial nodes- from upper lesser 
curvature) 
Supra pyloric group (right suprapanceatic nodes- from the antral segments of 
lesser curvature) 
Pancreaticolienal group (left gastroepiploic and splenic nodes-high on the 
greater curvature)  
Inferior gastric subpyloric group (along the right gastro epiploic vascular 
pedicle) 
Finally all lymphatics drains into coeliac group of lymph nodes  
 
FIGURE 7 
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ANATOMY OF DUODENUM: 
 Duodenum is the widest, shortest and fixed part of small intestine. 
 Extending from pylorus to duodeno-jejunal flexure. 
 Lies opposite to L2L3 vertebra above the umbilicus 
 Curved around the head of pancreas forming a letter C shape 
PARTS: 
The duodenum is 25cm long and 2.5cm wide which are divided into four 
anatomic parts. 
D1 - the cap / bulb (superior part-5cm) 
Lies anterolateral to the L1 body and overlain by liver and gall bladder, 
ampulla (cap)-first 2cm- bears a mesentery, the hepatoduodenal ligament, part 
of the lesser omentum 
Distal 3 cm retroperitoneal 
D2 - descending portion (7.5cm) 
Lies along the right side of L1-L3 bodies 
 Receives the outflow from bile and pancreatic ducts via the hepatopancreatic 
ampulla (vater) through the greater duodenal papilla (vater) 
Receives outflow from accessory pancreatic duct through the lesser duodenal 
papilla.  
D3 - transverse portion (10cm) 
Crosses the L3 body and it lies posterior to the main trunk of superior 
mesenteric artery 
 
 
 
18 
 
D4 - ascending portion (2.5cm) 
Lies left of the L3 to upper border of L2 and becomes continuous with D-J 
flexure. 
 
 
FIGURE 8 
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ARTERIAL SUPPLY: 
 The part of the duodenum before the opening of bile duct is supplied by 
coeliac trunk through superior pancreatico duodenal artery and distal to the 
opening of bile duct supplied by inferior pancreatico duodenal artery. 
1st part of the duodenum receives additional supply from 
1. right gastric artery  
2. supraduodenal artery of wilke ( branch of hepatic artery) 
b. retroduodenal branches of gatroduodenal artery 
VENOUS DRAINAGE: 
Veins drain into splenic vein, superior mesenteric vein and portal vein. 
LYMPHATIC DRAINAGE: 
Flows through -pancreatic duodenal nodes, hepatic nodes, superior mesenteric 
nodes and ends up to intestinal lymph trunk- cisterna chyli. 
NERVE SUPPLY: 
Sympathetic nerve from Thoracic ninth to tenth spinal segments 
Parasympathetic nerve-vagus through coeliac plexus to reach dudodenum 
along the arteries. 
  
 
 
20 
 
ARTERIAL SUPPLY: 
 
FIGURE 9 
VENOUS DRAINAGE: 
     
FIGURE 10 
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PEPTIC ULCER DISEASE: 
  These are multiple erosions which occurs in the stomach or duodenum 
due to disruption of mucosal barrier which extends to the muscularis mucosae. 
This can be divided in to two subtypes 
 gastric ulcer 
 duodenal ulcer 
The most important etiological factor being commonly associated 
1. H.pylori   
2. Stress  
3. drugs like analgesics 
4. steroids 
5. surgeries 
HELICOBACTER PYLORI: 
Marshall & Warren from Australia in 1982, cultivated a organism of 
spiral shaped similar to Campylobacter which colonizes the stomach of human 
is present in patients with type – B gastritis (chronic inflammation of stomach 
antrum). 
It is named as campylobacter pyloridi are and then changed to the 
campylobacter pylori. Since the  organism was supposed to be  considered of 
taxonomical variant from other campylobacter species, due to  the presence of 
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sheathed flagella, a different respiratory quinines, a unique fatty acid profile,  
and a different 16s RNA sequence, the they created a new genus Helicobacter.  
It is more common in the lower socioeconomic group. 
H. pylori is associated mainly with peptic ulcer disease, type – B 
gastritis, gastric associated lymphoid tissue (MALT) B- cell lymphomas, 
gastric adeno carcinoma. 
Duodenal ulcer - 95% 
Gastric ulcer - 70% 
Gastritis - 70 – 90% 
MECHANISM RESPONSIBLE FOR GI INJURY: 
H. pylori releases UREASE the enzyme which hydrolyses urea & 
releases ammonia which via negative feedback mechanism there by it increases 
gastrin release from G – cells. 
It also secretes enzyme DEHYDROGENASE (which converts alcohol 
to aldehyde a toxic metabolite to the mucosa), ENDOPEPTIDASE (which 
intervene the mucosal barrier). 
Urease the enzyme released will create alkaline environment around it 
in mucus layer of gastric epithelium. It will survive only in gastric epithelium 
/gastric metaplasia in the duodenum/Barrett’s oesophagus/ and in heterotrophic 
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gastric mucosa in meckel’s diverticulum/rectum since the receptors available 
only in gastric mucosa for these organism to get adhered. 
H.pylori affects the mucosal healing and degranulates eosinophils. It 
secretes cytotoxins such as (cag A and vac A) causing inflammatory reaction or 
malignancy. . It releases proteases & lipases which breaks mucus & the barrier. 
HABITAT : 
In stomach, present only in the mucous layer of gastric epithelium 
mostly involving the antrum (humans) 
BLOOD :  
H. pylori also identified from the patient having malignant lymphoma of 
the upper GIT including stomach via blood culture. 
FAECES: 
Polymerase chain reaction are done to identify the H.pylori in faeces. 
ORAL CAVITY: 
H. pylori occasionally were isolated from the saliva and also from dental 
plaques.  
ANIMAL SOURCES: Rhesus monkey, baboon, pigs& domestic cats 
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FIGURE 11 
 
FIGURE 12 
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FEATURES :( microbiological) 
Cellular features :  
• H. pylori is a gram negative rod shaped flagellated organism of (0.5 -
0.9 micro meters wide and 2-4micro meters long). 
• Has 1 to 3 turns when observed in vivo. 
• In light microscopy, Helicobacter cells have about 5-6 polar 
(lophotrichous) flagella. 
•  Motile via polar flagella and produce large amount of urease 
PHYSIOLOGICAL FEATURES : 
• H. pylori are microaerophilic organisms  
• It grows well in an atmosphere (5% O2 with 5 - 10% CO2), and on 
blood containing media like “brain heart infusion agar” (BHI). 
• BHI has  5% horse blood agar with 1% Isovitalex. 
• Temperature range of 33 to 40 degree Celsius.  
• pH 5.5 – 8.5. 
BIOCEMICAL FEATURES : 
Positive Features                       Negative Features 
Urease Production                      Nitrate reduction 
Cytochrome Oxidase                 Hippurate hydrolysis 
Catalase production                   Carbohydrate Oxidation / fermentation 
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VIRULENCE FACTORS: 
Heat shock protein 
Cag A and Vac A proteins 
Leukocyte recruitment and activating factors 
Lipopolysaccharide (LPS) 
UREASE SPECIFIC FEATURE: 
 Urease contains nickel which will digests urea, there by bypasses freely 
from plasma to the gastric juice producing AMMONIA. 
NH2-CO-NH2 + H2O → CO2 + 2NH3    
                                At neutral pH 
           NH3 + H2O → NH4OH → NH4+ + OH- 
H. pylori infected patients, has less urea and more ammonia than the 
normal patients in gastric juice.  
Ammonia released by H. pylori due to the Urease activity it buffers the 
bacterial hydrogen ions which is present in gastric acid juice, so that providing 
a source of nitrogen for H.pylori.  
WAYS OF SPREAD: 
• Faeco-Oral route- it is seen in subjects consuming uncooked 
vegetables  
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• Oro-Oral route-Rate of infection in children affected from H.pylori 
positive parents due to presence of the similar strain in the family 
member which suggest, close contact is one of  the important modality 
for the spread of infection 
• Gastro-Oral route: aspirated gastric juice, this route may account for 
endoscopist ,nurses and theatre staff 
MANAGEMENT OF H.PYLORI INFECTION:  
INVESTIGATIONS: 
 INVASIVE METHODS: 
• Rapid  urease  test  (CLO / Campylobacter  like  organism Test)  
• Histology 
• Culture 
NON INVASIVE METHODS: 
o Serology  
o Urea  breath  test  
RAPID UREASE TEST: 
• It is a rapid  diagnostic  test  which is used  for  H.pylori which is  
based  on the enzyme   urease  
• Tissue sample  is  put  into  a  solution  containing  urea, with  
(phenol  red)  as a  pH  indicator  and  a  gel  which contains  
bacteriostatic  agent 
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• Result -If  H. pylori  are  present,   urease  will hydrolyses the urea 
and   releases  two molecules  of  ammonia  and  one  molecule  of  
carbon dioxide there by   raising the  pH  and  alkalinising   the  
medium  which is appreciated by colour change (yellow colour to  
pink) 
• The test has High specificity (95-100%) and good sensitivity (90-
100%) 
• False negative test seen in atrophic gastritis with achlorhydria 
HISTOLOGY : 
• Giemsa staining 
• Standard  haematoxylin  and  eosin  stain 
• Warthin – Starry Stain 
• Gretna  stain 
• Alcian  blue  
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H.PYLORI 
 
FIGURE 13 
CULTURE: 
It can  be  isolated  in  culture  if  the  specimen  is  inoculated into an  
enriched medium  which is supplemented  with  blood,  hemin  or  charcoal  
and further  incubated  in  a  microaerophilic  atmosphere  for  upto  2  weeks. 
POLYMERASE  CHAIN  REACTION :  
• It is used to detect H.  pylori  in  the  fecal  samples.  PCR  is  more  
sensitive  on comparing all other  culture  methods since  it  does  not  
depend  on  bacterial  viability 
• Limiting  factors  are  inhibitors  of  amplification  reaction  in  feces.  
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SEROLOGY / ELISA: 
Serological test can be done for detection of IgG,IgM and  IgA  
antibodies. The systemic IgG response is most commonly used parameter to 
detect the H.pylori infection.The advantages of serological test are non 
invasive ,inexpensive, easy technique and not affected by prior antibiotics and 
PPI and it has high sensitivity and specificity compared to invasive test and 
urea breath test 
UREA BREATH TEST: 
• Urea  along  with   C 13 which is a non-radioisotope ,  is  hydrolysed  in  
the  stomach  by  the  enzyme  urease  secreted  from  H. pylori  to  
produce  two  molecules  of  ammonia  and  one  molecule  of carbon 
dioxide which is  excreted  via  lungs  as  exhaled  air. 
• Breath  samples  are  collected  before  the  administration  of  C 13  
• CO2  is  then  calculated  using  an  isotope  ratio  mass  spectrometer  
[IRMS].  
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FIGURE 14 
 
TABLE  1 : SENSITIVITY, SPECIFICITY AND COST  OF 
DIAGNOSTIC  TESTS  FOR  H.PYLORi 
Methods 
Sensitivity 
(%) 
Specificity 
(%) 
cost invasive 
Culture 98 100 ++++ Yes 
Histology 98 99 ++++ yes 
CLO 90 100 +++ Yes 
Breath 100 100 ++ No 
Serology 98 96 + No 
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TREATMENT OF H.PYLORI: 
ERADICATION REGIMEN: 
Triple  therapy   
2  antibiotics and one proton pump inhibitor for 7-14 days. 
• PPI ( omeprazole 20 mg bid  or  rabeprazole 20mg  bid or 
lansoprazole30 mg bid  or  pantoprazole  40mg bid)  
• amoxicillin 1 g  bid  
• clarithromycin  500mg bid  
• metronidazole 500mg bid (can be used  instead of amoxicillin)  
Quadraple therapy   : includes PPI   plus  bismuth  subsalicylate with 
tetracycline and metronidazole incoporated 
ANTIBODY TESTING AFTER H PYLORI ERADICATION:   
After  the  eradication  of  Helicobacter  pylori,  the  serum  IgG  and  
IgA  levels  falls  very  slowly.  After  6  weeks  of  eradication,  titres  falls  by  
20-30%  and  after  six  months  titres  falls  by  50%  in  97%  of  patients.  
Since  there  is  a  slow  fall  in  the  antibody  titre,  it  is  not  commonly  used  
to  assess  the  success  of  treatment.  Thus  the  success  of  treatment  is  
assessed  by  repeat  endoscopy,  histology  and  culture  and  urea  breath  test.  
One  study  showed  that  antibody  titre  in saliva  specific  to  Helicobacter  
pylori  were  found  to  be  reduced  more  fastly.  More  than  50%  patient  
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have  shown  83%  fall  in  antibody  titre  of  saliva  with  treatment  after  one  
month.  
Thus  it  is  used  as  standard  methods  to monitoring  Helicobacter  
pylori eradication.  ELISA  is  the  best   method  for  serology  because  of  its  
simplicity,  reliability,  and  low  cost. 
Seroconversion takes  22-23  days  after  the  infection.   
Sensitivity  and  Specificity  of  ELISA  is  over  90%.  
PEPTIC ULCER DISEASE: 
 Peptic ulcer disease is caused by increased aggressive factors and 
decreased defensive factors or both, this  in turn leads to mucosal damage and 
ulceration. Most majority of peptic ulcer disease is caused by H.pylori 
infections or NSAIDS 
 Peptic ulcer disease can be gastric or duodenal ulcer 
GASTRIC ULCER: 
Gastric ulcers usually present on the lesser curvature near the Incisura 
about 60 % and these ulcers(type 1 ulcer) are not associated with excessive 
acid secretion with low to normal acid output. In contrast, type 2 gastric 
ulcers(15%) are located in the body of the stomach in association with 
duodenal ulcer. Type 3 ulcers are prepyloric ulcers and account for about 20% 
.Type 2 and 3 ulcers are associated with excessive acid secretions. Type 4 
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ulcers occur near the OG junction and account less than 4 % and associated 
with normal acid level  
Gastric ulcers occur in age between 55-65 years ,low socioeconomic 
class and female to male ratio of 2:1. Presence of acid is essential to produce 
gastric ulcers ,so rapid healing occurs following an effective Antacids therapy   
NSAIDS induced ulcers are most often found in the stomach ,so 
ingestion of NSAIDS remains as the important factor in ulcer pathogenesis by 
breaking the mucosal barrier and the risk of bleeding and ulceration is directly 
proportional to the dosage of NSAIDS especially in the older age group(more 
than 60) and patient with concurrent use of steroids or anti-coagulant. NSAIDS 
users have a two to ten fold increased risk for GI complications   
 
ETIOLOGY: 
1. H.pylori(75%) 
2. atrophic gastritis 
3. gastric stasis 
4. duodenogastric bile reflux 
5. abnormalities in acid and pepsin secretion 
6. smoking 
7. alcohol 
8. NSAIDS 
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9. Steroids 
10. Low socioeconomic group 
FACTORS RESPOSIBLE OF GASTRIC ULCER: 
 Due to gastric stasis- acid stagnant leading to mucosal eruption 
 Duodenogastric reflux- bile and lysolecithin breaks the mucosa barrier 
 Type 2 and 3 gastric ulcers leads to hypersrection of acids 
PATHOPHYSIOLOGIC ABNORMALITIES IN GASTRIC ULCER: 
 Increased serum levels of pepsinogen2 
 Increased duodenogastric reflux 
 Decreased gastric parietal cell mass 
 Decreased maximal acid output 
MORPHOLOGY: 
GROSS MORPHOLOGY: 
Margins of benign gastric ulcers are clear( in lesser curvature) ,edges are 
not everted with gastric mucosal folds which converges to the base of ulcer 
HISTOLOGICAL MORPHOLOGY: 
 Shows ulcer crater  containing inflammatory cells and granulation tissue 
and epithelial proliferation and end arteritis obliterans. 
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CLINICAL FEATURES: 
1. Equal in both sex, being more commonly associated with females 
2. Above the age of 40yrs 
3. EPIGASTRIC PAIN AFTER TAKING FOOD which last upto 2 
hours and relieved by vomiting 
4. Has symptom free interval of 2-3months 
5. Haemetemesis is more common 
6. Loss of weight 
7. Good appetite but once full blown complication occurs appetite will 
decrease 
COMPLICATIONS: 
 PERFORATION is the most common complication of gastric 
ulcer(into the lesser sac) 
 Hour glass contracture(due to cicatrisation of lesser curvature) 
 Tea pot deformity(due to cicatrisation and shortening of lesser 
curvature) 
 Bleeding (due to involvement of LGA)  
 Penetration(posterior to pancreas & anteriorly to liver) 
 Malignant transformation- ADENOCARCINOMA (5-10%) 
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DUODENAL ULCERS: 
Duodenal  ulcers  occurs  most commonly  in  the  duodenal  cap  region 
and acid  should  be  there  for  non-malignant  ulceration involving the 
upper GIT. There is a large overlap of acid levels between the ulcer 
patients and normal subjects. Almost 70% of duodenal ulcer patients 
have a normal acid output.NSAID induced ulcers are mostly found in 
the stomach on comparing to H.pylori induced ulcers are most 
commonly found in the duodenum.  
ETIOLOGY: 
 H.pylori (95%) is the important etiological factor 
 Stress 
 Anxiety (hurry,worry,curry) 
 NSAIDS 
 Steroids 
 Smoking 
 Alcohol 
 Vitamin deficiency 
 Endocrinological factors: Zollinger elison syndrome, MEN 1 
,Cushing syndrome, hyperparathyroidism 
 Chronic pancreatitis 
 Cirrhosis 
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PATHOPHYSIOLOGICAL ABNORMALITIES IN DUODENAL 
ULCER: 
 Decreased duodenal HCO3 secretion (most common) 
 Increased nocturnal acid secretion 
 Increased duodenal acid loss 
 Increased day time acid secretion 
 Increased gastric emptying 
 Increased pentagastrin -stimulated Mean acid output 
 Decreased PH inhibition on acid release 
 
MORPHOLOGY: 
GROSS MORPHOLOGY: The serosa of the involved duodenal ulcer part 
shows petechial haemorrhages along with speckled red dots looking like a 
sprinkled -CAYENNE PEPPER 
 
HISTOLOGICAL MORPHOLOGY: 
 Ulcer along with chronic inflammatory cells with granulation tissue 
 Gastric metaplasia of duodenal mucosa 
  End arteritis obiters 
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CLINICAL FEATURES: 
1. DUODENAL ULCER incidence is more comparing to gastric ulcers 
in INDIA 
2. More common in TYPE A personality people 
3. More common in males 
4. PAIN produced in the early morning, decreased after food 
intake (occurring before food (HUNGER PAIN) 
5. Malena is more common 
6. Periodicity with seasonal variation occurs 
7. Heart burn, water brash and vomiting is present 
8. Appetite is good- eats frequently and gains more weight 
 
COMPLICATIONS OF DUODENAL ULCER: 
1. Intractable duodenal ulcer 
2. Bleeding 
3. Perforation  
4. Obstruction (Rule out malignancy/ pyloric stenosis) 
5. Residual abscess 
6. Penetration into pancreas 
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PEPTIC ULCER PERFORATION: 
It may occur in both Duodenal and Gastric ulcer 
Due to perforation, the gastroduodenal contents will spill into the 
peritoneal cavity which will result to gross chemical peritonitis. In the early 
stage visceral contents are sterile ,so infective peritonitis is very rare ,but the 
features and prognosis depends on the general condition of the patient. 
 
CLASSIFICATION OF PERFORATION: 
 Acute perforation 
 Subacute perforation 
 Chronic perforation 
 Perforation associated with haemorrhage 
 Perforation of intrathoracic gastric ulceration 
 Pseudoperforation 
1. ACUTE PERFORATION: 
Here the ulcer perforate and occurs the spillage of gastric and duodenal 
contents into the peritoneal cavity there by resulting to Chemical Peritonitis 
Clinical features depends on the stage of perforation. 
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Three stages of perforation, each of variable duration are as follows 
a. Primary stage or stage of peritonism 
b. Secondary stage or stage of peritoneal reaction 
c. Tertiary stage or stage of bacterial peritonitis 
1. Primary stage: 
The clinical course in perforation is classical. Vigorous agonizing pain 
starts in the epigastrium or right hypochondrium first and later turns into a 
generalized pain.  
The patient then becomes prostrated. Symptoms are due to irritation of 
the peritoneum by gastroduodenal contents spillage. 
Pain shock may occur. Abnormal temperature, cold peripheries, 
sweating, palpitation, radiation of abdominal pain to both the shoulders as the 
diaphragm gets irritated, pale face.  
Patient will assume a classical rigid posture by lying with legs updrawn 
and hands will be held tensely by his side. Temperature will be subnormal, as 
low as 95 – 96 degree or normal. Pulse rate may be  normal or raised above 90 
per minute. Shallow Respiration with increased respiratory rate may be there. 
 Per abdomen examination reveals, restricted or no movements of 
abdomen with respiration with prominent rectus muscle. On palpation warmth 
and diffuse tenderness is noted. Guarding and rigidity will be present. Bowel 
sounds will be absent on auscultation  
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The stage of which  lasts for 3 – 6 hours. 
The Perforated fluid may leak into Right Para colic gutter which will 
cause inflammation and pain, there by mimicking the features of acute 
appendicitis. 
2. Secondary stage: 
Transition time from the primary stage to secondary stage will be taking 
around 3-6 hours which will be depending on the size and site of perforation 
and amount of peritoneal soiling. 
During this stage the spontaneous sealing of perforation may occur. 
Gross leakage of gastroduodenal contents, will lead the patient to stage of 
septic peritonitis which will rarely exceeds 6 hours. 
 Here the pain is lessened markedly with general condition 
improvement. Because of this stage of reaction it has sometime called stage of 
delusion and it is in this stage most of error in diagnosis takes place. 
 On examination varying amount of rigidity of abdomen and tenderness 
will be present with  Bowel sounds are infrequently heard or absent 
3. Tertiary Stage : 
Stage of diffuse peritonitis which begins about 12 hours of perforation 
and lasts for about 24 hours until it passes Into final stages of paralytic 
intestinal obstruction. Gross contamination by Pathogenic organisms is likely 
here. 
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 Peritoneal fluid will become purulent with bowel loop distension with 
fluid and gas. Intestinal movements diminish and finally disappear with onset 
of paralytic ileus. 
 The clinical features are same as those of generalized peritonitis from 
any other cause with less Pain ,frequent vomitus, hiccoughs which may further 
depress the patient.  
Sweating, vomiting, outpouring of fluid into peritoneal cavity, distended 
paralysed intestine, dehydration and electrolyte imbalance becomes more 
severe. 
 Patient  will complaints of intense thirst, elevated temperature, dry & 
coated tongue, rapid thread pulse, shallow and rapid respiration. 
 Abdomen is distended, guarding still persists. On auscultation 
occasional tinkles heard. The typical Hippocratic facies denote that end is not 
far off  
Patient drifts into toxaemic stage, dehydration and circulatory failure.   
Patient will die usually 4-5 days after perforation 
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2. SUBACUTE  PERFORATION : 
The  ulcer may perforate but the  peritoneum will seal rapidly before 
there is spillage of duodenal contents, into general peritoneal cavity. There will 
be sudden onset of acute abdominal pain more  to the right upper quadrant. 
Respiration will be shallow and on deep inspiration it may be associated with 
an abrupt catch in the breath 
On examination, there is localised tenderness and rigidity, leaving 
behind the rest of the abdomen soft on palpation and non-tender– ray film 
usually reveals only a  small amount of gas under diaphragm. Patient’s 
symptoms will usually subside in half an hour to 2 hours .  Rarely  it extend 
and the signs of an acute perforation develop 
3. Chronic perforation : 
It occurs when an  ulcer perforated into an area which is  walled off 
by adhesions or by adjacent viscera like liver, colon or greater omentum or 
it may also occurs when gastric ulcer perforates into omental sac there by 
leading to a chronic abscess there by making the diagnosis confusable. 
Since  these patients doesn’t  present with classical signs and 
symptoms of peritonitis, they are seldom diagnosed as peptic ulcer 
perforation. Irregular temperatures, rigors, leucocytosis, dullness at the base 
of the lung, Consequent pleural effusion or basal congestion will lead to the 
diagnosis of sub phrenic abscess, containing gas and diaphragm is raised 
and fixed on right side. 
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 USG of abdomen -most reliable investigation of choice for 
intraperitoneal abscess  
4. Perforation associated with haemorrhage: 
Perforation with massive haemorrhage is grave but fortunately a very 
rare complication. It will occur in one of  the three ways 
a. Haemorrhage and perforation occurring concomitantly 
b. Haemorrhage following a recently sutured perforation 
c. Perforation occurring during the medical treatment of  haemorrhage 
The clinical features will be similar to acute perforated peptic ulcer with 
signs of haemorrhage  
5. Perforation of an intra-thoracic gastric ulcers: 
An extremely rare variety of perforation. Here the ulcer will be in hiatus 
hernia, which will be fixed in the mediastinum. Unless we identify the hiatus 
hernia, it will be  extremely difficult to make a proper pre – operative 
diagnosis.  
Since  the symptoms and signs will be pointing an intra thoracic lesions 
such as coronary thrombosis, acute pericarditis, pulmonary embolism. 
Rare type Perforated peptic ulcer : 
  Peptic ulcer in meckel’s diverticulum in intestinal duplication may 
occasionally perforates. Simultaneously multiple perforations occur in less than 
one percent of all cases. 
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CLINICAL FEATURES OF PEPTIC ULCER PERFORATION: 
AGE :  
 Duodenal ulcer perforation is rare before adolescence, common in 30-40 
years age group and it is the most common type. 
 Gastric ulcer Perforation the mortality is very high 
 SEX: 
 More common in men than in women 
HISTORY OF PRESENT ILLNESS : 
Time on onset : the patient is able to exact the time of onset of 
perforation, most commonly after an exertion  
Mode of onset : sudden  
Pain : Pain is extremely vigorous in the abdomen ,more in the 
epigastrium and  then spreads all over the abdomen 
Shifting of pain : shift to right iliac fossa since the fluid flows threw the 
right paracolic gutter in order to settle in the right iliac fossa ; thus 
mimicking features of acute appendicitis 
Radiation of pain : pain in peptic ulcer perforation is referred to the tip 
of right shoulder 
Nausea : may be present 
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Vomiting : early stage -reflex vomiting will be there since because of 
irritation of nerves in peritoneum and mesentery. Later stage- vomiting 
occurs because of toxin acting at the level of medullary centres and 
because of this paralytic ileus occurs. The vomitus contains undigested 
food materials & blood occasionally  when haemorrhage is seen. 
Abdominal distension:patient may present with significant abdominal 
distension in late stage of perforative peritonitis. 
Micturition: oliguria will be seen in shock patients. 
PAST HISTORY :  
Dyspepsia will be seen in 80% of cases. Rest of all the cases, perforation 
will be the very first  clinical manifestation of a silent duodenal ulcer 
PHYSICAL EXAMINATION: 
General appearance : Initially during the shock of perforation, patient 
will present with pale face with sweating. 
Decubitus : supine, rigid and immovable, staying in the similar posture 
refusing any movements. 
Pulse : normal at early perforation (beginning),  rapid and thready when 
full blown peritonitis sets in. 
Respiration : early stage no change occurs,it becomes rapid & shallow 
when full blown peritonitis sets in or it may also seen in perforation with 
haemorrhage . 
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Temperature : initially normal, rises with onset of peritonitis. 
Tongue : moist initially and becomes dry and brown when peritonitis 
sets in. 
EXAMINATION OF ABDOMEN : 
Respiratory movements : thoracic movement dominates over the 
abdominal movements along with respiratory effort 
Rigidity of abdomen : constant, continuous  rigid abdomen is 
characteristic which occurs due to reflex contraction of the abdominal 
muscles and it will be  predominantly seen in the epigastrium and right 
hypochondrium.  
Liver dullness : liver dullness obliteration is characteristic of this 
abdominal condition usually evident in the second stage. 
Free fluid : free fluid is present . 
Rectal examination :  
 Fullness noted in rectovesical or rectovaginal pouch in late stage. 
INVESTIGATIONS : 
1. X-ray abdomen erect: 
Plain X – ray erect of the abdomen demonstrates free air 
under the diaphragm.  
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FIGURE 15 
 
X-RAY SHOWING AIR UNDER DIAPHRAGM 
2. Gastroduodenogram:  
Following injection of 60ml of gastrograffin via the nasogastric 
tube X-ray abdomen erect taken. 
INFERRENCE: dye escapes via the  perforation, thereby 
enabling to demonstrate the site and size of perforation, chronicity, 
associated gastric ulcer and other second ulcer. 
3. Ultrasound examination: 
Performed with multi frequency probe (3.5 – 5 MHz) 
Intra peritoneal free fluid along with decreased intestinal 
peristalsis is considered be a finding of perforation indirectly. 
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4. Computerized tomographic examination : 
CT – scanning is rarely required for diagnosis as clinically it is 
easily diagnosed. However some patients with perforated duodenal 
ulcer  on steroid therapy or hospitalized bed ridden patients for other 
abnormalities will develop occult causes of abdominal pain and 
sepsis. At that time Gatrograffin swallow and / or CT scanning may 
be required to determine the cause on occult abdominal sepsis 
5. Serum amylase : 
Normal value of serum amylase is 80 – 180 somogyi units. Above 
200 units is considered pathological. Mortality is high when it is 
seen in peptic ulcer perforation. 
Helicobacter Pylori infection diagnosis : 
The diagnosis of helicobacter pylori infections is done by following 
different methods 
i. Non – invasive : a. serology – ELISA 
  b. urea breath test 
ii. Invasive test : a. rapid urease test  
                           b. histology 
                           c. culture 
6. Abdominal paracentesis :  
Four quadrant paracentesis to be done. 
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DIFFERENTIAL DIAGNOSIS: 
- acute medical conditions 
- acute surgical conditions 
ACUTE MEDICAL CONDITIONS : 
 Acute pericarditis  
 Coronary thrombosis  
 Lobar pneumonia  
 Pleurisy  
 Gastric crisis or tabes dorsalis  
 Acute alcoholism 
ACUTE SURGICAL CONDITIONS : 
 Acute pancreatitis  
 Ruptured ectopic gestation  
 Acute gastritis  
 Perforated typhoid ulcer  
 Acute exacerbation of duodenal ulcer  
 Peritonitis from acute appendicitis  
 Biliary colic in acute cholecystitis  
 Acute intestinal obstruction  
 Ruptured aortic aneurysm  
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SURGICAL TREATMENT : 
OPEN PROCEDURES :  
1. SIMPLE CLOSURE : 
- Most commonly performed surgery  for peptic ulcer perforation is 
simple closure with an omental onlay patch closure  
- Surgery is described by Graham 
- It is performed through upper midline Incision 
- After lavaging the peritoneal cavity of purulent or bilious fluid. 
Perforated ulcer site must be visualized and three commonly or may 
be occasionally four-zero (3-0 / 4-0) silks sutures should be  placed 
in the ulcer edge, passing through the wall of duodenum and it 
should be 0.5 – 1 cm from edge of perforation 
- Omentum will be laid over the simple closure and secured. 
- Suture must be applied long the long axis of the gut in order  to 
avoid luminal narrowing 
- Additional sutures can be placed as a plication for omental catch 
2. Cellan Jones technique, Graham technique : free omental flap is used 
here. Greater omentum is used as a sealer for perforation closure 
3. Omental drag into perforation site  and plugging it into the Ryle’s 
tube  
4. Rectus muscle use in order to seal perforation 
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DUODENAL PERFORATION 
 
FIGURE 16 
 
GASTRIC PERFORATION 
                        
FIGURE 17 
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PERFOATION CLOSURE METHOD 
               
FIGURE 18 
 
 
 
FIGURE 19 
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After combining with post-operative H. Pylori eradication the morbidity 
and mortality and ulcer recurrence rate after primary closure and omental onlay 
technique,  have been shown acceptably low. 
Since no significant alteration in gastrointestinal anatomy with ulcer 
closure -patient doesn’t suffer from post Vagotomy or post gastrectomy side 
effects. 
DEFINITIVE SURGERY: 
Patients with peptic ulcer perforation usually presents with unstable 
Conditions. So we do damage control surgery. But in various conditions we 
recommend definitive surgery if patients presented with stable vitals and 
coexistence of bleeding or obstruction and with initial presentation of less than 
8hrs duration 
 In case of duodenal perforations ,  primary closure of perforation with 
omental patching done + definitive procedures (truncal vagotomy  + 
pyloroplasty ) 
 In case of gastric perforation primary closure of perforation with 
omental patching done+ definitive procedures 
o Type 1 -  distal gastrectomy with bilroth I or II reconstruction 
o Type 2 and 3 – truncal vagotomy plus antrectomy 
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TRUNCAL VAGOTOMY  
It is performed by the division of right and left vagus nerve above 
hepatic and celiac branches just above gastroesophageal junction. It is usually 
done along with a drainage procedure like heineke-mikulicz pyloroplasty or 
finney pyloroplasty. It is usually associated with low reoccurrence rate and 
high incidence rate of post vagotomy syndromes.it is most commonly done for 
duodenal ulcers. 
 
HIGHLY SELECTIVE VAGOTOMY 
This highly selective vagotomy is also called parietal cell vagotomy or 
proximal  gastric vagotomy.this procedure divides only the vagus nerves 
supplying the acid producing portion of the stomach within the corpus and 
fundus. This procedure also preserves the vagal innervations of gastric antrum 
so that there is no need for rout ne drainage procedures. This is usually 
associated with high recurrence rate and low incidence of post vagotomy 
complications. 
TRUNCAL VAGOTOMY AND ANTRECTOMY: 
The main goal of this procedure is removing vagal stimulation along 
with removal of gastrin driven secretion by performing an antrectomy.it is 
more effective in reducing acid secretion and reccurrence than truncal 
vagotomy in combination with a drainage procedure or a highly selective 
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vagotomy.the recurrence rate of ulceration after truncal vagotomy  with 
antrectomy is low about  0-2%.however they are associated with high rates of 
post vagotomy and post gastrectomy syndromes of around 20%. 
 
POST OPERATIVE COMPLICATIONS: 
 Pulmonary complications like- atelectasis and pneumonia 
 Peritonitis 
 Residual abscess (pelvic and subphrenic abscess) 
 Paralytic ileus 
 DVT 
 Early perforation and leak and fistula 
 Renal failure 
 Mediastinitis  
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OBSERVATION AND ANALYSIS 
 
 
TABLE 2 : AGE WISE DISTRIBUTION OF CASES IN PEPTIC ULCER 
PERFORATION 
AGE GROUP (AGE IN YEARS) NUMBER OF CASES PERCENTAGE 
13 to 20yrs 5 10.00% 
21 to 30yrs 13 26.00% 
31 to 40yrs 4 8.00% 
41 to 50yrs 10 20.00% 
51 to 60yrs 9 18.00% 
61 to 70yrs 7 14.00% 
71 to 80yrs 2 4.00% 
Total 50 100.00% 
Mean: 43.16 / Median: 45.00 / S.D.: 17.117 / Min.: 15 / Max.: 77 
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FIG 20 :  BAR DIAGRAM SHOWING AGE WISE DISTRIBUTION OF 
CASES IN PEPTIC ULCER PERFORATION 
 
 
 
 Maximum(26%) number of patients belong to the age group of 21-30 
years. 
 Minimum(4%) number of patients belong to the age group of 71-80 
years. 
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TABLE 3 - SEX WISE DISTRIBUTION OF CASES IN PEPTIC ULCER 
PERFORATION 
SEX NUMBER OF CASES PERCENTAGE  
Male 43 86.00% 
Female 7 14.00% 
Total 50 100.00% 
 
FIG 21 ; BAR DIAGRAM SHOWING SEX WISE DISTRIBUTION OF 
CASES IN PEPTIC ULCER PERFORATION 
 
In our study 86% of patients were found be MALE and 14% patients were 
found to be FEMALE . 
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TABLE 4 - TYPE OF PERFORATION IN TOTAL  
NUMBER OF CASES 
TYPE OF PEFORATION NUMBER OF CASES PERCENTAGE 
Duodenal perforation 34 68.00% 
Gastric perforation 16 32.00% 
Total 50 100.00% 
 
FIG 22:  BAR DIAGRAM SHOWING TYPE OF PERFORATION IN 
ALL CASES OF PEPTIC ULCER PERFORATION 
 
 
 
In our study duodenal perforation were found to be 68% and gastric perforation 
were found to be 32% 
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TABLE 5 : H.PYLORI POSITIVE CASES IN PEPTIC ULCER 
PERFORATION 
H.PYLORI STATUS NO OF CASES PERCENTAGE 
Positive 39 78.0 
Negative  11 22.0 
Total 50 100.0 
 
FIG 23 : BAR DIAGRAM SHOWING H.PYLORI POSITIVE CASES IN 
PEPTIC ULCER PERFORATION 
 
 
In Our study showed that 78 % of patients were found to be Positive for 
H.PYLORI and 22% were found to be Negative 
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TABLE 6 : COMPARISON OF RAPID UREASE TEST AND HPE FOR 
DETECTION OF H.PYlORI 
  
H.PYLORI 
POSITIVE NEGATIVE 
N % n % 
RUT 39 78 % 11 22 % 
HPE 39 78 % 11 22 % 
 
FIG 24 : BAR DIAGRAM SHOWING COMPARISON OF RUT AND 
HPE IN DETECTION OF H.PYLORI 
 
 
In Our study showed that both RUT and HPE has same sensitivity in detection 
of H.pylori  
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TABLE 7 : RELATION OF RISK FACTOS WITH PERPTIC ULCER 
PERFORATION: 
RISK FACTORS NO OF CASES PERCENTAGE 
Alcohol 37 74% 
Smoking 35 70% 
Tobacco 27 54% 
Spicy foods 30 60% 
NSAIDS 18 36% 
APD 35 70% 
H.pylori +ve 39 78% 
 
FIG 25 :  BAR DIAGRAM SHOWING RELATION OF RISK FACTORS 
WITH PEPTIC ULCER PERFORATION 
 
In our study we found that maximum number of the patients (39) i.e. 
78% shows H.pylori as a common risk factor  & Alcohol (74%) is the 2nd most 
common risk factor ,followed by smoking and Dyspepsia (70%) contributes for 
peptic ulcer perforation. 
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TABLE 8 : RELATIONSHIP BETWEEN THE TYPE OF 
PERFORATION AND H.PYLORI STATUS: 
TYPE OF 
PERFORATION 
H.PYLORI 
POSITIVE NEGATIVE TOTAL 
N % N % n % 
GASTRIC 11 28.20% 5 45.45% 16 36.0% 
DUODENAL 28 71.80% 6 54.54% 34 64.0% 
Total 39 100.0% 11 100.0% 50 100.0% 
 
FIG 26 :  BAR DIAGRAM SHOWING RELATION BETWEEN TYPE 
OF PERFORATION AND H.PYLORI STATUS IN PEPTIC ULCER 
PERFORATION 
 
In our study duodenal perforation( 28 patients (71.80%) )Were found to be 
positive for H.pylori Gastric perforation only 11 patients were H.pylori 
positive. 
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TABLE 9 : AGE WISE DISTRIBUTION OF H.PYLORI POSITIVE 
CASES IN PERFORATED PEPTIC ULCER 
AGE 
H.PYLORI STATUS 
POSITIVE NEGATIVE Total 
n % n % n % 
13 to 20yrs 5 12.8% 0 .0% 5 10.0% 
21 to 30yrs 10 25.6% 3 27.3% 13 26.0% 
31 to 40yrs 1 2.6% 3 27.3% 4 8.0% 
41 to 50yrs 9 23.1% 1 9.1% 10 20.0% 
51 to 60yrs 6 15.4% 3 27.3% 9 18.0% 
61 to 70yrs 6 15.4% 1 9.1% 7 14.0% 
71 to 80yrs 2 5.1% 0 .0% 2 4.0% 
Total 39 100.0% 11 100.0% 50 100.0% 
 
 
FIG 27 : BAR DIAGRAM SHOWING AGE WISE DISTRIBUTION OF 
H.PYLORI POSITIVE CASES IN PEPTIC ULCER PERFORATION 
 
0
2
4
6
8
10
12
13 to
20yrs
21 to
30yrs
31 to
40yrs
41 to
50yrs
51 to
60yrs
61 to
70yrs
71 to
80yrs
POSITIVE
NEGATIVE
 
 
67 
 
Chi square – 0.113 df – 6 P > 0.05 
           
Maximum number of H.PYLORI positive cases(25.6%) belongs to the age 
group of 21-30 years and maximum number of H.PLYORI negative cases 
belongs to the age group of 21-40 years (27.3%) 
 
TABLE 10 : SEX WISE DISTRIBUTION OF H.PYLORI POSITIVE 
CASES IN PERPTIC ULCER PRFORATION 
SEX 
H.PYLORI 
POSITIVE NEGATIVE Total 
n % n % n % 
Male 34 87.2% 9 81.8% 43 86.0% 
Female 5 12.8% 2 18.2% 7 14.0% 
Total 39 100.0% 11 100.0% 50 100.0% 
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FIG  28 :  BAR DIAGRAM SHOWING SEX WISE DISTRIBUTION OF 
H.PYLORI POSITIVE CASES IN  
PEPTIC ULCER PERFORATION 
 
 
Chi square – 0.651 df – 1 P > 0.05 
 
In our study incidence of HYPLORI in males were found to be 87.2% and in 
females were found to be 12.8% 
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TABLE – 11 : COMPARISON OF ALCOHOLISM AND H.PYLORI 
STATUS 
ALCOHOL 
H.PYLORI 
POSTIVE NEAGATIVE TOTAL 
n % n % N % 
Present 28 71.8% 9 81.8% 37 74.0% 
Absent  11 28.2% 2 18.2% 13 26.0% 
Total 39 100.0% 11 100.0% 50 100.0% 
 
FIG 29 : BAR DIAGRAM SHOWING COMPARISON OF 
ALCOHOLISM AND  H. PYLORI STATUS IN PEPTIC ULCER 
PERFORATION 
 
Chi square – 0.503 df – 1 P > 0.05 
 
Interpretation: Observed difference in alcohol and the result of HPYLORI 
status is not significant (P>0.05) 
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TABLE 12 : COMPARISON OF TOBACCO AND  
H.PYLORI STATUS 
TOBACCO 
H.PYLORI 
POSTIVE NEAGATIVE TOTAL 
n % n % N % 
Present 21 53.8% 6 54.5% 27 54.0% 
Negative 18 46.2% 5 45.5% 23 46.0% 
Total 39 100.0% 11 100.0% 50 100.0% 
 
FIG 30 :  BAR DIAGRAM SHOWING COMPARISON OF TOBACCO 
AND H. PYLORI STATUS IN PEPTIC ULCER PERFORATION 
 
Chi square – 0.967 df – 1 P > 0.05 
 
Interpretation: Observed difference in tobacco and the result of HPYLORI 
status is not significant (P>0.05) 
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TABLE 13: COMPARISON OF SPICY FOODS AND  
H.PYLORI STATUS 
SPICY FOODS 
H.PYLORI 
POSTIVE NEGATIVE TOTAL 
n % n % n % 
Positive 23 59.0% 7 63.6% 30 60.0% 
Negative 16 41.0% 4 36.4% 20 40.0% 
Total 39 100.0% 11 100.0% 50 100.0% 
 
FIG 31: BAR DIAGRAM SHOWING COMPARISON OF SPICY 
FOODS AND H. PYLORI STATUS IN PEPTIC ULCER 
PERFORATION 
 
Chi square – 0.780 df – 1 P > 0.05 
 
Interpretation: Observed difference in spicy foods and the result of 
HPYLORI status is not significant (P>0.05) 
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TABLE 14: COMPARISON OF NSAIDS AND H.PYLORI STATUS 
NSAIDS 
H.PYLORI 
POSITIVE NEGATIVE TOTAL 
n % n % n % 
Positive 9 23.1% 9 81.8% 18 36.0% 
Negative 30 76.9% 2 18.2% 32 64.0% 
Total 39 100.0% 11 100.0% 50 100.0% 
 
 
FIG 32: BAR DIAGRAM SHOWING COMPARISON OF NSAIDS AND 
H. PYLORI STATUS IN PEPTIC ULCER PERFORATION 
 
Chi square – 0.000 df – 1 P < 0.05 
 
Interpretation: Observed difference in NSAIDS and the result of H. PYLORI 
status is SIGNIFICANT (P<0.05) 
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TABLE 15: COMPARISON OF SMOKING AND  
H.PYLORI STATUS 
SMOKING 
H.PYLORI 
POSTIVE NEGATIVE TOTAL 
n % n % n % 
Present 27 69.2% 8 72.7% 35 70.0% 
Negative 12 30.8% 3 27.3% 15 30.0% 
Total 39 100.0% 11 100.0% 50 100.0% 
 
 
FIG 33: BAR DIAGRAM SHOWING COMPARISON OF SMOKING 
AND H. PYLORI STATUS IN PEPTIC ULCER PERFORATION 
 
Chi square – 0.823 df – 1 P > 0.05 
 
Interpretation: Observed difference in smoking and the result of HPYLORI 
status is not significant (P>0.05) 
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TABLE 16: COMPARISON OF APD AND H.PYLORI STATUS 
APD 
H.PYLORI 
POSITIVE NEGATIVE TOTAL 
n % n % n % 
Positive 33 84.6 2 18.2 35 70.00% 
Negative 6 15.4 9 81.8 15 30.00% 
Total 39 100.0% 11 100.0% 50 100.0% 
 
 
FIG 34: BAR DIAGRAM SHOWING COMPARISON OF APD AND H. 
PYLORI STATUS IN PEPTIC ULCER PERFORATION 
 
Chi square – 0.000 df – 1 P < 0.05 
 
Interpretation: Observed difference in APD and the result of HPYLORI status 
is SIGNIFICANT (P<0.05) 
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TABLE 17: RELATIONSHIP BETWEEN RISK FACTORS OF PEPTIC 
ULCER PERFORATION AND H.PYLORI STATUS 
RISK FACORS 
H.PYLORI 
POSTIVE NEGATIVE TOTAL 
n % N % n % 
Male 34 87.2% 9 81.8% 43 86.0% 
Female 5 12.8% 2 18.2% 7 14% 
Alcohol 28 71.8% 9 81.8% 37 74% 
Smoking 27 69.2% 8 72.7% 35 70% 
Tobacco 21 53.8% 6 54.5% 27 54.0% 
Spicy foods 23 59% 7 63.6% 30 60% 
NSAIDS 9 23.1% 9 81.8% 18 36.0% 
APD 33 84.6% 2 18.2% 35 70% 
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FIG 35: BAR DIAGRAM SHOWING RELATION BETWEEN RISK 
FACTORS OF PEPTIC ULCER PERFORATION AND H.PYLORI 
STATUS 
 
 
In our study we found that APD is most commonly associated with H.pylori 
positive patients (33) i.e. 84.6% and followed by alcohol (71.8%) and smoking 
(69.2%). 
 
Patient with NSAIDS intake had low prevalence of H.pylori positivity i.e. 
(23.1%). 
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TABLE 18 - RELATIONSHIP BETWEEN H.PYLORI AND 
SOCIOECONOMIC STATUS 
SOCIOECONOMIC 
STATUS 
H.PYLORI 
POSITIVE NEGATIVE TOTAL 
N % N % n % 
HIGH 3 7.69% 0 0.00% 3 6% 
MEDIUM 16 41.02% 6 54.54% 22 44% 
LOW 20 51.28% 5 45.45% 25 50%% 
Total 39 100.0% 11 100.0% 50 100.0% 
 
FIG 36:  BAR DIAGRAM SHOWING RELATION BETWEEN 
SOCIOECONOMIC STATUS AND H.PYLORI STATUS 
 
In our study we found that H.pylori positive cases were more in LOW 
SOCIOECONOMIC STATUS patients about 51.28% and followed by 
MEDIUM SOCIOECONOMIC STATUS patients i.e. 41.02% 
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DISCUSSION 
 
In this study, most of the patients were middle aged (21 – 30 years) out 
of 50 patients, 43 were males and 7 were females in the ratio of 4: 1 
In our study 74% of patients had history of alcohol, 70% of patients had 
history of smoking and acid peptic disease, only 36% of patients had history of 
NSAID’s use. 
Out of 50 cases studied, 34 patients (68.00%) were found to have 
duodenal perforation and 16 patients (32.00%) were found to have gastric 
perforation 
In our study, prevalence of H.pylori infection in peptic ulcer perforation 
was 78% (39 cases out of 50). This result was in accordance with study by 
Sebastian et al. In their study, they reported infection rate of 83 %. 
But some studies reported the prevalence of H.pylori infection was in 
the range of 50 – 90 %. This wide variation could be due to different 
population group, routine use of proton pump inhibitors for treatment of upper 
gastrointestinal symptoms.  According to study by Connor et al using PPI in 
peptic ulcer disease shows false negative results with rapid urease test. In our 
study 39 (78%) patients were positive for H.pylori out of which 28 patients 
were of duodenal perforation and only 11 patients were having gastric 
perforation. 
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In our study, the association of H.pylori infection with duodenal 
perforation was more. i.e., 28 out of 34 duodenal ulcer perforation cases found 
to H.pylori positive (82%). This was corresponding to Ng et al. in their study; 
they found 70 % prevalence of H.pylori infection with duodenal perforation. 
In this study, rapid urease test and Giemsa stain had same validity while 
detection of H.pylori. But in Kumar et al study, found H.pylori infection state 
of 57% by means of  rapid urease test, histopathological examination, and 
culture method and reported H.pylori infection rate of 70% by rapid urease test 
method. 
In the study, 50 cases of peptic ulcer perforation, H.pylori status positive 
for most of the middle aged persons (21-30 years) – 25.6 %. 
Out of 39 cases of H.pylori positive patients, 34 were males and 5 were 
females in ratio of 7 : 1. But in A Shin et al and Maria Rodrigues found that 
there was no difference in prevalence of H.pylori infection in males and 
females. 
In our study, we compared various risk factors with H.pylori infection. 
Among them, patient with history of acid peptic disease had high incidence of 
H.pylori infection. i.e., 84.6% which was significant in our study, followed by 
alcohol (71.8%) and smoking which were not significant in our study. But 
patients with NSAID’s had low H.pylori infection rate 23.1%. This was similar 
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to the study of Asud ullah et al. In their study history of dyspepsia had 87% of 
H.pylori infection   and NSAID’s has 9% of H.pylori infection. 
In our study, out of 50 patients 39 (93.0%) were positive for H.pylori. 
They were treated with anti H.pylori regimen by administration of  standard 
triple therapy for 14 days. The remaining 11 patients were given only 
Cap.omeprazole 20mg bd for 14 days.  
In our study most of the patients had no dyspepsia except only one 
patient who had dyspepsia inspite of anti H.pylori treatment. We gave a 
repeated course of same drug and had no dyspepsia. 
  
 
 
81 
 
CONCLUSION 
 
In our study we found that H.pylori infection was the most common risk 
factor for peptic ulcer perforation and the patients of peptic ulcer perforation 
with dyspepsia had a high prevalence rate of H.pylori infection. Therefore if 
we treat these patients with anti H.pylori triple therapy postoperatively we can 
reduce the recurrence of ulcer and reperforation . Early diagnosis and 
controlling of the H.pylori infection in dyspepsia  patients  may reduce the 
incidence of peptic ulcer perforation and can  prevent the morbidity and 
mortality of the patient.    
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PROFORMA 
  
Name:             IP  No:  
Age:              SL   No:  
Sex:              Date  of  admission:  
Occupation:            Date  of  surgery:  
Religion:            Date  of  discharge:  
  
PRESENTING  COMPLAINTS:  
Pain  Abdomen:  
Fever:  
Vomiting:  
Distension  of  Abdomen:  
Constipation:  
 
PAST  HISTORY: 
Surgeries:  
Medical  conditions:  Diabetes / Hypertension / Tuberculosis / Asthma / 
Epilepsy  
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FAMILY  HISTORY: 
PERSONAL  HISTORY:  
Diet:             Sleep:  
Bowel / Bladder:       Smoker / Alcoholic:  
EXAMINATION GPE:  
Pallor:           Icterus:  
Cyanosis:          Clubbing:  
Lymphadenopathy:  
Vitals:   Pulse  rate:                      Blood   Pressure:                     RR:          
 SYSTEMIC  EXAMINATION:  
Per  Abdomen:   
Cardiovascular  System:  
Respiratory  System:  
Central  Nervous  System:  
DIAGNOSIS:  
INVESTIGATIONS:  
Hb %:       TC:        
RBS:  
  DC:    ESR: 
Blood  urea:    
Serum  creatinine:  
  BT:    CT:  
X – ray  erect  abdomen:      
USG  abdomen:  
  ECG:   
HIV:             HBsAg:   
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PREOPERATIVE  PREPARATION:  
NPO,   RTA,   Injection  TT, Injection  Xylo  test  dose,  IV  Antibiotics,   
Preparing  of  relevant  parts;  Informed  High  risk  consent  
 
PROCEDURE:  
Anaesthesia:      Position:       
Exploratory  laparotomy  +  perforation  closure  +  grahams  patch:  
Postop:      Antibiotic:      Analgesic:    
COMPLICATIONS:  
FOLLOWUP:  
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CERTIFICATE  OF  CONSENT 
 
I have  read  the  foregoing  information,  or  it  has  been  read  to  me.  I  
have  had  the  opportunity  to  ask  questions  about  it  and  any  questions  
that  I  have  asked  have  been  answered  to  my  satisfaction.  I  consent  
voluntarily  to  participate  as  a  participant  in  this  research  and  understand  
that  I  have  the  right  to  withdraw  from  the  research  at  any  time  without  
in  any  way  affecting  my  medical  care.  
Name  of  participant __________________________  
Signature  of  Participant _______________________  
Date _________________________  
If  illiterate  
A  illiterate  witness  must  sign  ( if  possible,  this  person  should  be  selected  
by  the  participant  and  should  have  no  connection  to  the  research  team).  
I  have  witnessed  the  accurate  reading  of  the  consent  from  to  the  
potential  participant,  and  the  individual  has  had  the  opportunity  to  ask  
questions.  I  confirm  that  the  individual  has  given  consent freely.  
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Name  of  participant __________________________  
Signature  of  Participant ________________________  
Date _________________________          
I  have   accurately  read  or  witnessed  the    accurate  reading  of  the  
consent  from  to  the  potential  participant,  and  the  individual  has  had  the  
opportunity  to  ask  questions.  I  confirm  that  the  individual  has  given  
consent freely.  
Name  of  participant __________________________  
Signature  of  Participant ______________________   
Date ______________________  
Thumb  print  of  participant  
 
  
A  copy  of  this  Informed  Consent  From  has  been  provided  to  
participant  _______________ ( initialled  by  the  researcher / assistant). 
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பuேகபவƫக¶t ஆவ} வபர 
ெச«ைற வளtக 
 
இ|த ஆவ பuேகபவƫக¶t அ²ைவ சிகிvைச ெச¢ ெகாzட 
ப}©, அ|த தைசைய ம¯{¢வ பƬேசாதைன ெச¢ ெகாz அத} 
வபர ெதƬ|¢ ெகாள «¸ மன¢ட} சமதிtகிேற}  
 
ஆராvசி  நிைலய  
ெபா¢ அ²ைவ சிகிvைச ¢ைற 
அர ம¯{¢வt கµƬ ம²  ம¯{¢வமைன  
ேகாய©{£ƫ  
 
இ|த ஆவ பu ெகாள ஒ~©tெகாகிேற} . எனt 
ெகாtக~பyட அறிºைரகள}ப நட|¢ ெகாவ¢ட} இ|த ஆைவ 
ேமெகா¶ ம¯{¢வ அணt உzைம­ட} இ¯~ேப} எ}² 
உ²தி அளtகிேற}. எ} உட நல பாதிtக~பyடாேலா அல¢ 
எதிƫபாராத வழtக{தி மாறான ேநாtறி ெத}பyடாேலா உடேன 
அைத ம¯{¢வ அணயட ெதƬவ~ேப} என உ²தியளtகிேற}   
 
 
பuேகபவƬ} ைகெயா~ப ...........................................................................................  
 
இட ..................................................                                               
நா ........................................... 
 
கyைட  வர  ேரைக 
 
பuேகபவƬ} ெபயƫ ம² வலாச  
.......................................................................................................................................... 
.......................................................................................................................................... 
 
ஆவாளƬ} ைகெயா~ப .....................................................................  
இட   : .......................................................... 
நா : .............................................................. 
ஆவாளƬ} ெபயƫ  : ..................................................................................................... 
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KEY TO MASTER CHART 
 
S.food  – Spicy Food 
NSAID  – Non-Steroidal Ani Inflammatory Drugs 
APD - Acid Peptic Disease 
RUT  –  Rapid Urease Test 
HPE  – Histopathological Examination 
HP kit  – Anti H.pylori kit 
OT kit – Omeprazole Therapy 
1 – positive 
2 – negative 
AUD  – Air Under Diaphragm 
H  – anti H.pylori therapy 
O – Omeprazole therapy 
ND – No dyspepsia 
D – Dyspepsia
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1 BHARATHAN 15 M 108946 M 2 2 2 1 2 1 1 1 1 1 1 AUD+ 1 1 DUODENAL PERFORATION H ND 
2 KUMAR 30 M 1511 M 1 1 2 1 2 1 1 2 1 2 1 AUD+ 1 1 DUODENAL PERFORATION H ND 
3 BIRENDRA 19 M 3203 M 2 2 2 1 2 1 1 1 2 1 1 AUD+ 1 1 DUODENAL 
PERFORATION 
H ND 
4 SATISH 30 M 12606 M 1 1 1 1 2 1 1 2 1 2 1 AUD+ 1 1 
DUODENAL 
PERFORATION H ND 
5 PAPPU 28 M 178852 L 1 1 1 1 2 2 1 1 1 2 1 AUD+ 2 2 DUODENAL PERFORATION O ND 
6 KANNISAMY 47 M 197687 H 1 1 1 1 2 1 1 1 1 1 1 AUD+ 1 1 GASTRIC 
PERFORATION 
H ND 
7 MUTHUKRISHNA 65 M 192974 L 1 1 1 2 2 1 1 2 1 1 1 AUD+ 1 1 
DUODENAL 
PERFORATION H ND 
8 MANI 65 M 192991 M 1 1 2 1 2 1 1 1 1 1 1 AUD+ 1 1 DUODENAL PERFORATION H ND 
9 BALASUBRAMANI 39 M 129702 M 1 1 2 2 1 2 1 1 1 2 1 AUD+ 2 2 GASTRIC 
PERFORATION 
O ND 
10 BATHIRAPAN 61 M 841 L 1 1 1 2 1 1 1 1 1 2 2 AUD+ 1 1 
DUODENAL 
PERFORATION H ND 
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11 RAMALINGAM 60 M 925 L 1 1 2 2 1 2 1 1 1 1 1 AUD+ 2 2 
GASTRIC 
PERFORATION O ND 
12 JAYAMMA 65 F 10864 L 2 2 1 2 1 1 1 1 1 1 1 AUD+ 1 1 DUODENAL PERFORATION H ND 
13 BANNARI 40 M 190665 L 1 1 1 2 2 2 1 1 1 1 1 AUD+ 1 1 GASTRIC PERFORATION H ND 
14 GANESH 29 M 38818 M 1 1 1 1 1 2 1 1 1 2 1 AUD+ 2 2 DUODENAL 
PERFORATION 
O D 
15 BAGADUR 58 M 46113 M 1 1 2 1 1 2 1 1 1 1 1 AUD+ 2 2 
DUODENAL 
PERFORATION O ND 
16 UDAIDULA 46 M 48494 M 1 1 2 1 2 2 1 1 1 1 2 AUD+ 1 1 GASTRIC PERFORATION H ND 
17 RAVIKUMAR 45 M 97298 M 1 1 1 2 2 1 2 1 1 1 1 AUD+ 1 1 DUODENAL 
PERFORATION 
H ND 
18 NAGARAJ 17 M 101780 L 2 2 2 1 2 1 1 2 1 1 1 AUD+ 1 1 
DUODENAL 
PERFORATION H D 
19 RAJASEKAR 30 M 106307 M 1 1 1 2 2 1 2 1 1 1 1 AUD+ 1 1 GASTRIC PERFORATION H ND 
20 MALLIAG 
ARJUNAN 
47 M 110833 L 1 2 1 1 2 1 1 1 1 1 2 AUD+ 1 1 GASTRIC 
PERFORATION 
H ND 
21 RAJESH 24 M 130547 L 1 1 1 1 2 1 1 1 1 2 1 AUD+ 1 1 
DUODENAL 
PERFORATION H ND 
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22 VIJAYAKUMAR 38 M 176476 L 1 2 1 2 1 2 2 1 1 1 2 AUD+ 2 2 
DUODENAL 
PERFORATION O ND 
23 ESWARI 30 F 52743 L 2 2 2 1 1 2 1 1 1 2 1 AUD+ 2 2 DUODENAL PERFORATION O ND 
24 RENUGA 19 F 130960 L 2 2 2 1 1 1 2 1 2 1 1 AUD+ 1 1 DUODENAL PERFORATION H ND 
25 ARIYAMMAL 49 F 62321 M 2 2 1 2 1 1 2 1 1 2 1 AUD+ 2 2 GASTRIC 
PERFORATION 
O ND 
26 SIVAGAMI 48 F 38323 M 2 2 1 2 1 2 2 1 2 1 1 AUD+ 1 1 
DUODENAL 
PERFORATION H ND 
27 MARIMUTHU 65 M 83764 L 1 1 1 2 1 1 2 1 2 1 1 AUD+ 1 1 GASTRIC PERFORATION H ND 
28 PERIYASAMY 57 M 9057 L 1 1 2 1 2 2 1 1 2 1 1 AUD+ 1 1 DUODENAL 
PERFORATION 
H ND 
29 PANDIYAN 47 M 9057 L 1 1 2 1 2 2 1 1 1 1 1 AUD+ 1 1 
DUODENAL 
PERFORATION H ND 
30 NANJAN 60 M 23369 M 1 1 1 2 1 1 1 1 1 1 1 AUD+ 1 1 DUODENAL PERFORATION H ND 
31 MYILSAMY 65 M 27570 M 1 1 2 1 1 2 1 1 1 1 1 AUD+ 2 2 DUODENAL 
PERFORATION 
O ND 
32 BHARATHAN 52 M 36282 M 1 1 2 1 2 1 2 1 1 2 1 AUD+ 1 1 
GASTRIC 
PERFORATION H ND 
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33 SARASWATHY 75 F 23698 L 2 2 1 2 1 1 1 1 1 1 1 AUD+ 1 1 
DUODENAL 
PERFORATION H ND 
34 RAJENDRAN 56 M 31045 L 1 1 2 1 2 1 2 1 2 1 1 AUD+ 1 1 DUODENAL PERFORATION H ND 
35 ANU 15 F 31252 H 2 2 2 1 1 1 1 1 1 2 1 AUD+ 1 1 GASTRIC PERFORATION H ND 
36 SURY 25 M 82082 L 1 1 2 2 2 1 1 2 1 1 1 AUD+ 1 1 DUODENAL 
PERFORATION 
H ND 
37 PONNUSAMY 55 M 83896 L 2 1 1 1 2 1 1 2 1 1 1 AUD+ 1 1 
GASTRIC 
PERFORATION H ND 
38 PALRAJ 45 M 87506 M 1 1 1 2 2 1 2 1 1 2 2 AUD+ 1 1 DUODENAL PERFORATION H ND 
39 SALEEM 25 M 4889 M 1 1 2 1 2 1 1 2 1 1 2 AUD+ 1 1 DUODENAL 
PERFORATION 
H ND 
40 RANGAN 55 M 16627 L 1 1 1 1 2 1 1 1 1 1 1 AUD+ 2 2 
GASTRIC 
PERFORATION O ND 
41 KARUPPUSAMY 65 M 3053 L 1 2 2 1 2 1 1 1 2 1 1 AUD+ 1 1 DUODENAL PERFORATION H ND 
42 SASIL 23 M 51670 H 1 1 2 2 2 2 1 1 1 1 2 AUD+ 1 1 DUODENAL 
PERFORATION 
H ND 
43 RAMARATHIANAM 56 M 83686 M 2 1 1 2 2 1 2 1 1 2 2 AUD+ 1 1 
DUODENAL 
PERFORATION H ND 
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44 ANBARASAN 33 M 13630 M 1 1 1 1 1 2 2 2 1 2 1 AUD+ 2 2 
GASTRIC 
PERFORATION O ND 
45 SUBBU 77 M 22887 L 1 1 1 1 1 1 1 2 1 1 1 AUD+ 1 1 DUODENAL PERFORATION H ND 
46 MUMMORTHY 27 M 946911 L 1 1 2 2 2 1 2 1 1 1 2 AUD+ 1 1 DUODENAL PERFORATION H ND 
47 KUMAR 22 M 105531 L 2 1 1 1 2 1 1 2 1 1 2 AUD+ 1 1 GASTRIC 
PERFORATION 
H ND 
48 JANAGAR 45 M 117415 L 1 1 2 1 2 1 1 2 1 1 1 AUD+ 1 1 
DUODENAL 
PERFORATION H ND 
49 BIRASH 24 M 133152 M 1 2 1 1 2 1 1 2 2 2 1 AUD+ 1 1 DUODENAL PERFORATION H ND 
50 THIRUMURGAN 45 M 131968 M 1 2 1 2 2 1 1 1 2 1 1 AUD+ 1 1 GASTRIC 
PERFORATION 
H ND 
 
